MORGAN D'ALESSIO: Open Payments
NPI 1952037004 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 22 payments from 11 companies in 2025. Trend: 2023 $418 · 2024 $632 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $220 |
| Davol Inc. | 1 | $123 |
| Janssen Biotech, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $52 |
| QOL Medical, LLC | 2 | $35 |
| Lilly USA, LLC | 1 | $22 |
| Acera Surgical, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: REZDIFFRA, Phasix Mesh, TREMFYA, DUPIXENT, Sucraid, CREON, OMVOH, Restrata Wound Matrix.
Industry payments across NJ — which companies pay providers there.
